These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2900144)

  • 1. Ethnic differences in response to beta-blockade: fact or artefact? A study with bisoprolol and propranolol.
    Joubert PH; Venter CP; Wellstein A
    Eur J Clin Pharmacol; 1988; 34(4):363-8. PubMed ID: 2900144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bisoprolol with other beta-adrenoceptor blocking drugs.
    Krämer B; Balser J; Stubbig K; Krämer G; Kübler W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S46-57. PubMed ID: 2439798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic haemodynamic and beta-adrenoceptor antagonistic effects of bisoprolol in conscious pigs: a comparison with propranolol.
    Duncker DJ; Saxena PR; Verdouw PD
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):54-63. PubMed ID: 2895611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic differences in response to beta 1-adrenoceptor blockade by propranolol.
    Venter CP; Joubert PH
    J Cardiovasc Pharmacol; 1984; 6(2):361-4. PubMed ID: 6200729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
    Sklar J; Johnston GD; Overlie P; Gerber JG; Brammell HL; Gal J; Nies AS
    Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B; Cronin CJ; Graham BR; Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bisoprolol on local vascular resistance.
    Bailliart O; Kedra AW; Bonnin P; Savin E; Martineaud JP
    Eur Heart J; 1987 Dec; 8 Suppl M():87-93. PubMed ID: 2897303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic differences in beta-1-adrenoceptor sensitivity.
    Venter CP; Joubert PH
    S Afr Med J; 1982 Nov; 62(23):849-50. PubMed ID: 6755764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential haemodynamic effects induced by beta 1-(bisoprolol) or beta 2-(ICI 118,551) adrenoceptor blockade in man.
    Daul A; Johnston T; Reher M; Krüger M; Brodde OE
    J Hypertens Suppl; 1986 Dec; 4(6):S99-102. PubMed ID: 2886573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic evaluation of bisoprolol after coronary artery surgery in patients with altered left ventricular function.
    Goldstein M; Vincent JL; Le Clerc JL; d'Hollander A; Melot C; Kahn RJ
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):629-33. PubMed ID: 1678965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
    Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response studies of indenolol, a beta adrenoceptor blocker.
    Okupa FE; Daneshmend TK; Shrosbree E; Roberts CJ
    Clin Pharmacol Ther; 1981 Apr; 29(4):434-9. PubMed ID: 6110504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of beta-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exercise.
    Cockburn JA; Brett SE; Guilcher A; Ferro A; Ritter JM; Chowienczyk PJ
    Br J Clin Pharmacol; 2010 Apr; 69(4):329-35. PubMed ID: 20406217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for cardiac beta 2-adrenoceptors in man.
    Brown JE; McLeod AA; Shand DG
    Clin Pharmacol Ther; 1983 Apr; 33(4):424-8. PubMed ID: 6299641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
    Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of S-596, a new beta-adrenoceptor blocking agent on the left ventricular performance of normal subjects during exercise.
    Nishida K; Niki S; Furukawa K; Yamada C; Sugihara H; Katsume H; Ijichi H
    Jpn Heart J; 1985 May; 26(3):437-49. PubMed ID: 2411959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
    Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.